Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Long-term effects of smallpox vaccination on expression of the HIV-1 co-receptor CCR5 in women.

Beck KB, Hønge BL, Olesen JS, Petersen MS, Jespersen S, Wejse C, da Silva ZJ, Medina C, Té DDS, Moeller BK, Benn CS, Aaby P, Erikstrup C.

PLoS One. 2018 Nov 15;13(11):e0207259. doi: 10.1371/journal.pone.0207259. eCollection 2018.

2.

Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.

Dubey S, Khalid M, Wesley C, Khan SA, Wanchu A, Jameel S.

J Clin Virol. 2008 Sep;43(1):25-31. doi: 10.1016/j.jcv.2008.03.026. Epub 2008 May 6.

PMID:
18462992
3.

CCR5 expression, haplotype and immune activation in protection from infection in HIV-exposed uninfected individuals in HIV-serodiscordant relationships.

Jaumdally SZ, Picton A, Tiemessen CT, Paximadis M, Jaspan HB, Gamieldien H, Masson L, Coetzee D, Williamson AL, Little F, Gumbi PP, Passmore JS.

Immunology. 2017 Aug;151(4):464-473. doi: 10.1111/imm.12743. Epub 2017 May 24.

4.

The Effect of Smallpox and Bacillus Calmette-Guérin Vaccination on the Risk of Human Immunodeficiency Virus-1 Infection in Guinea-Bissau and Denmark.

Rieckmann A, Villumsen M, Jensen ML, Ravn H, da Silva ZJ, Sørup S, Baker JL, Rodrigues A, Benn CS, Roth AE, Aaby P.

Open Forum Infect Dis. 2017 Jun 20;4(3):ofx130. doi: 10.1093/ofid/ofx130. eCollection 2017 Summer.

5.

The number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study.

Meijerink H, Indrati AR, van Crevel R, Joosten I, Koenen H, van der Ven AJ.

BMC Infect Dis. 2014 Dec 13;14:683. doi: 10.1186/s12879-014-0683-0.

6.

Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy.

Kourtis AP, Ibegbu CC, Theiler R, Xu YX, Bansil P, Jamieson DJ, Lindsay M, Butera S, Duerr A.

J Infect Dis. 2007 Apr 1;195(7):965-72. Epub 2007 Feb 20.

PMID:
17330786
7.

Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice.

Ringpis GE, Shimizu S, Arokium H, Camba-Colón J, Carroll MV, Cortado R, Xie Y, Kim PY, Sahakyan A, Lowe EL, Narukawa M, Kandarian FN, Burke BP, Symonds GP, An DS, Chen IS, Kamata M.

PLoS One. 2012;7(12):e53492. doi: 10.1371/journal.pone.0053492. Epub 2012 Dec 31.

8.

Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection.

Zaunders JJ, Dyer WB, Wang B, Munier ML, Miranda-Saksena M, Newton R, Moore J, Mackay CR, Cooper DA, Saksena NK, Kelleher AD.

Blood. 2004 Mar 15;103(6):2238-47. Epub 2003 Nov 26.

9.

CCR5 and CCR3 expression on T CD3+ lymphocytes from HIV/Leishmania co-infected subjects.

Nigro L, Rizzo ML, Vancheri C, La Rosa R, Mastruzzo C, Tomaselli V, Ragusa A, Manuele R, Cacopardo B.

Med Microbiol Immunol. 2007 Dec;196(4):253-5. Epub 2007 Apr 25.

PMID:
17457607
10.

[Deep lung--cellular reaction to HIV].

Tavares Marques MA, Alves V, Duque V, Botelho MF.

Rev Port Pneumol. 2007 Mar-Apr;13(2):175-212. Review. Portuguese.

11.

Low expression of activation marker CD69 and chemokine receptors CCR5 and CXCR3 on memory T cells after 2009 H1N1 influenza A antigen stimulation in vitro following H1N1 vaccination of HIV-infected individuals.

Chawansuntati K, Chotirosniramit N, Sugandhavesa P, Aurpibul L, Thetket S, Kosashunhanan N, Supindham T, Kaewthip O, Sroysuwan P, Sirisanthana T, Suparatpinyo K, Wipasa J.

Hum Vaccin Immunother. 2015;11(9):2253-65. doi: 10.1080/21645515.2015.1051275. Epub 2015 Jun 19.

12.

CCR5 antagonism impacts vaccination response and immune profile in HIV-1 infection.

Westrop SJ, Moyle G, Jackson A, Nelson M, Mandalia S, Imami N.

Mol Med. 2012 Oct 24;18:1240-8. doi: 10.2119/molmed.2012.00206.

13.

Does smallpox vaccination modify HIV disease progression among ART-naive people living with HIV in Africa?

Diouf A, Trottier H, Youbong TJ, Ngom-Guéye NF, Ndiaye O, Seck A, Sarr D, Diop S, Seydi M, Mboup S, Nguyen VK, Jaye A.

Epidemiol Infect. 2018 Jan;146(2):218-226. doi: 10.1017/S0950268817002795. Epub 2017 Dec 13.

14.

GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells.

Schwarze-Zander C, Neibecker M, Othman S, Tural C, Clotet B, Blackard JT, Kupfer B, Luechters G, Chung RT, Rockstroh JK, Spengler U.

Antivir Ther. 2010;15(5):745-52. doi: 10.3851/IMP1602.

15.

Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).

Wharton M, Strikas RA, Harpaz R, Rotz LD, Schwartz B, Casey CG, Pearson ML, Anderson LJ; Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee.

MMWR Recomm Rep. 2003 Apr 4;52(RR-7):1-16.

16.
17.

Smallpox vaccination and patients with human immunodeficiency virus infection or acquired immunodeficiency syndrome.

Bartlett JG.

Clin Infect Dis. 2003 Feb 15;36(4):468-71. Epub 2003 Jan 30.

PMID:
12567305
18.

Flow cytometry and T-cell response monitoring after smallpox vaccination.

Poccia F, Gioia C, Montesano C, Martini F, Horejsh D, Castilletti C, Pucillo Lp, Capobianchi MR, Ippolito G.

Emerg Infect Dis. 2003 Nov;9(11):1468-70.

19.

Regulation of CC chemokine receptor 5 in hepatitis G virus infection.

Nattermann J, Nischalke HD, Kupfer B, Rockstroh J, Hess L, Sauerbruch T, Spengler U.

AIDS. 2003 Jul 4;17(10):1457-62.

PMID:
12824783
20.

CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression.

Reynes J, Portales P, Segondy M, Baillat V, André P, Avinens O, Picot MC, Clot J, Eliaou JF, Corbeau P.

AIDS. 2001 Sep 7;15(13):1627-34.

PMID:
11546936

Supplemental Content

Support Center